19 May 2013
Keywords: alliance, pharma, starts, ph, iii, trial, apl202
Article | 17 January 2005
Alliance Pharma of the UK says it has commenced its registration trial program for APL202 (misoprostol), which is under investigation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com